Foot & Ankle Specialist (FAS) is a bimonthly journal offering peer-reviewed clinical information for foot and ankle caregivers. Written and edited by podiatrists and orthopaedic surgeons, FAS offers the latest techniques and advancements in foot and ankle treatment through research reports and reviews, technical perspectives, case studies, and other evidence-based articles. FAS enables practitioners to address a broad range of disorders and provide their patients with the best current diagnosis and therapy.
Foot and Ankle Specialist is a must-read for foot and ankle specialists such as:
- Podiatric Surgeons
- Orthopaedic Surgeons
- Plastic Surgeons
- Nerve Specialists
- Wound Specialists
- Nurse Practitioners
- Physician Assistants
- Podiatric Assistants
- Physical Therapists
- Topics covered in the journal include:
- Ankle Instability & Arthritis
- Sports Podiatry/Orthopaedics
- Diabetic Foot & Wound Care
- Heel Pain/Plantar Fasciitis/Heel Spurs
- Dermatology/Skin Care
- Surgeries and Infection
The content is divided into four sections: Practice, Research, Business, and Equipment.
This journal is a member of the Committee on Publication Ethics (COPE).
|John M. Schuberth, DPM||Chief, Foot and Ankle Surgery, Dept of Orthopedic Surgery, Kaiser Foundation Hospital, San Francisco, CA, USA|
|W. Bret Smith||Director of Foot and Ankle Division, Moore Center for Orthopedics, University of South Carolina, Columbia, SC, USA|
|Gregory C. Berlet||Orthopedic Foot and Ankle Center, Department of Orthopedics, The Ohio State University, USA|
|Lowell Weil, Jr., DPM, MBA||CEO, Weil Foot and Ankle; Fellowship Director, Weil Foot and Ankle Institute, USA|
|Gregory C. Berlet||Orthopedic Foot and Ankle Center, Department of Orthopedics, The Ohio State University, USA|
|Babak Baravarian, DPM, FACFAS||Chief of Podiatry at Santa Monica UCLA and Orthopedic Hospital, USA|
|Stephen A. Brigido||Director, Fellowship for Foot and Ankle, Reconstruction Coordinated Health, Bethlehem, PA, USA|
|Anand M. Vora, MD||Illinois Bone & Joint Institute, Chicago, IL, USA|
|Emily A. Cook, DPM, MPH, CPH||Clinical Instructor in Surgery, Harvard Medical School, Director of Resident Training, Department of Surgery, Mount Auburn Hospital, Cambridge, MA, USA|
|Sergio Abello, MD||Ortopedia y Traumatogia Clínica Shaio, Bogota, Colombia|
|Charles Andersen, MD, FACS, FAPWCA||Chief of the Vascular/Endovascular Surgery Service and Medical Director of the Wound Care Clinic, Madigan Army Medical Center, USA|
|David G. Armstrong, DPM, PhD||Director of Lower Extremity Research and the Southern Arizona Limb Salvage Alliance, University of Arizona, USA|
|Wang Bibo, MD||Shanghai Ruijin Hospital, Medicine School of Shanghai Jiaotong Univerity, China|
|Thomas J. Chang, DPM||Redwood Orthopaedic Surgery Associates, USA|
|Lawrence A. DiDomenico, DPM, FACFAS, FACFAOM, CWS||Reconstructive Rearfoot & Ankle Surgical Fellowship|
|Ivica Ducic, Dr., MD, PhD||Georgetown University Hospital, USA|
|Lawrence A. Ford, DPM||Richmond Medical Center, Richmond, CA, USA|
|Lisa Gould, MD, PhD, FACS||Wound Recovery and Hyperbaric Medicine Center, Kent Hospital, USA|
|Suzanne Hawson, PT, MPT, OCS||University Foot and Ankle Institute, USA|
|Christopher F. Hyer, DPM, FACFAS||Orthopedic Foot and Ankle Center, USA|
|Christian Kinast, Dr.med.||Orthopaedie Zentrum Arabellapark, Muenchen, Germany|
|Jonathan Labovitz, DPM, FACFAS||Western University of Health Sciences|
|Tun Hing Lui, MBBS(HK)||Department of Orthopaedics and Traumatology, North District Hospital, Hong Kong|
|Xin Ma, MD, PhD||Huashan Hospital Fudan University, China|
|Peter G. Mangone, MD||Blue Ridge Bone & Joint Clinic, Asheville, NC, USA|
|Tristan Meusnier, MD||Clinique Saint Charles, Lyon, France|
|Murray J. Penner, MD, FRCSC||University of British Columbia, Canada|
|Mark A. Reiley||Berkeley Orthopaedic MEdical Group, Inc., USA|
|Kevin B. Rosenbloom, C.Ped||Foot In Motion, Inc., USA|
|Niten Singh, MD||Chief, Endovascular Surgery, Madigan Army Medical Center, USA|
|Dishan Singh, MBChB, FRCS(Orth)||Royal National Orthopaedic Hospital, Stanmore, UK|
|David Soomekh, DPM||University Foot and Ankle Institute, USA|
|Thomas Zgonis, DPM, FACFAS||Department of Orthopaedics/Podiatry, The University of Texas Health Science Center, USA|
Foot & Ankle Specialist Manuscript Submission Guidelines
Editorial Purpose and Policies
Foot & Ankle Specialist (FAS) serves as a multidisciplinary journal dedicated to advancement of foot and ankle care. The primary audiences for FAS are podiatric surgeons and orthopaedists specializing in foot and ankle care. Authors should focus on the needs and interests of these individuals with particular emphasis on clinical relevance to any data cited or recommendations made.
The journal welcomes review and research articles in addition to technical articles, letters to the editor, case reports, practice-based, treatment dilemmas, advancements in foot and ankle specialization care, and equipment usage. Please note that the journal will prioritize original research submissions over case reports submissions.
There are monthly department columns, including:
- Technology column: an approximate 1,500-word first-person column about technological developments or what is going on in a foot and ankle surgeon's practice
- Master Surgeon: an approximate 1,500-word first-person column on a new surgical technique you use or are familiar with, or a step-by-step technique column on a topic such as reconstructive surgery, arthritis, etc.
- In the Profession: a 1,500-3,000 word educational column centered on research topics within the foot and ankle specialties. It should include descriptive information about various issues involving research for the foot and ankle surgeon, and not merely present the author’s opinion. The purpose of the column is to present topics not covered in research articles (such as business/administrative issues or pros and cons of industry regulations). Sample topics include “Why do we need an IRB and what is a Private IRB,” “What is 510K clearance and how are medical devices approved by the FDA, and “What is considered 'Off-label Use' and how does this effect the Foot and Ankle Practitioner”.
- Roundtable Discussion
- Current Trends in Foot and Ankle Surgery
- Evolving Techniques: The technique is a 3,000 word (4 pages max) article that must follow the folowing criteria. The technique must be innovative and must be abiding by standard of care and within scope of practice of author. The article must be evidenced-based and cinical follow-up should be a minimum of 1 year.
Manuscripts will be reviewed by at least two reviewers in a double-blind peer review. Manuscripts are considered with the stipulation that they are submitted solely to FAS and that no part of the submission has previously appeared elsewhere. Where questions exist, authors should submit copies of material that has appeared elsewhere. It is the author’s responsibility to obtain and submit permission for any copyrighted material in the manuscript (such as, tables or figures).
As the landscape of publishing continues to evolve, SAGE has revised its author archiving policy, resulting in increased openness for authors. Click here to read more about our archiving policy.
Submission of Manuscripts
Manuscripts should be submitted electronically to http://mc.manuscriptcentral.com/fas. Authors will be required to set up an online account on the SageTrack system powered by ScholarOne.
Questions regarding manuscript submission or preparation can be directed to:firstname.lastname@example.org.
Manuscripts must be prepared and submitted in the manner described in the American Medical Association’s Manual of Style. Transfer of copyright to Sage Publications is a condition of publication (authors will receive a copyright transfer form prior to publication). Upon acceptance of manuscript, please submit signed transfer of copyright forms to the attention of Stephanie Henkel at Sage Publications, 2455 Teller Road, Thousand Oaks, CA 91320; email: email@example.com; phone:805-410-7664.
- The manuscript is typed on white paper, 22 × 28 cm (8½ × 11 in.), with margins of at least 2.5 cm (1 in.) at top, bottom, and both sides.
- Use double spacing.
- Arrange the manuscript with the following sections and begin each section on a separate page: (1) title page, (2) abstract, (3) key words, (4) Level of Evidence, (5) text, (6) references, (7) glossary (if needed), (8) tables (each table on a separate page), (9) figures, and (10) legends.
- Abbreviated terms are spelled out at first use and followed with the abbreviation in parentheses. Avoid overuse of contrived abbreviations.
- Written permission to use non-original material (quotations exceeding 100 words, any table or illustration) from both author and publisher of the original is included, and the source is credited in the manuscript. No article will be accepted as a submission to FAS without all required permissions.
- Title page: Include (1) the full title of the paper—short, clear, and specific; (2) authors’ full names, (3) degrees and institutional affiliation of all authors; (4) name, address (including zip code), e-mail address, and phone number of all contributing authors; (5) a running title of 3 or 4 words; (6) any acknowledgments; and (7) any conflicts of interest or funding information. Indicate the author to whom communications should go to regarding the manuscript and reprint requests.
- Abstract: Provide an article summary of 200 words or less.
- Key words: Include 4-5 key words.
- Grant and other acknowledgments: Specify support of any work discussed, by a grant or otherwise, as well as the meeting, if any, at which the paper was presented (including place and date).
It is the author’s responsibility to disclose any potential conflict of interest regarding the manuscript, as specified on the transfer of copyright form. Additionally, any identifying information regarding a patient should be removed from the manuscript or informed consent from the patient will be required.
Statements and opinions expressed in the articles and communications appearing in the journal are those of the author(s) and not necessarily those of the editors and publisher. The editors and publisher disclaim any responsibility or liability for such material. Neither the editors nor the publisher guarantee, warrant, or endorse any product or service advertised in this publication, nor do they guarantee any claim made by the manufacturer of such product or service.
Level of Evidence
The journal requires that authors self-report Level of Evidence and Study Design in their submission (for example, Therapeutic, Level IV: Retrospective). For more information on the Level of Evidence guidelines of the journal, which closely mirror those of other orthopaedic journals, click here. Our editors will review your classification and reserve the right to change it. The author will be informed if there is a difference of opinion regarding classification. The Level of Evidence should be listed after the abstract within the main document.
Double-space references throughout, number them in the sequence in which they appear in the text, and identify them in text by superscript Arabic numerals. Accuracy and completeness of references are the author’s responsibility. References follow the American Medical Association’s Manual of Style. If there are more than 6 authors, the first 3 authors are used followed by “et al” including names and initials of all authors. Index Medicus abbreviations are used for journal titles, volume, inclusive page numbers, and year:
- Journal: Mazze RI, Cousins MJ, Kosek JC. Strain differences in metabolism and susceptibility to the nephrotoxic effects of methoxyflurane in rats. J Pharmacol Exp Ther. 1973;184:481-488.
- Book: Baston HC. An Introduction to Statistics in the Medical Services. Minneapolis, Minn: Burgess; 1956:110-114.
- Chapter: Cohen PJ, Marshall BE. Effects of halothane on respiratory control in rat liver mitochondria. In: Fink BR, ed. Toxicity of Anesthetics. Baltimore, Md: Williams and Wilkins; 1968:24-36.
- Tables: Double space on pages separate from the text. Tables should not duplicate material text or illustrations.
- Legends: Credit for any previously published illustration must be given in the corresponding legend. All symbols should be explained in the legend.
Electronic Art Submission
Acceptable file formats:
- TIFF (identified *.TIF) Tag Image File Format
- EPS (identified *.EPS) Encapsulated Postscript File
- JPEG (identified *.JPG) Joint Photographic Experts Group
- The submission system will NOT accept PDF files
- Line art (black and white) should be scanned at 1200 dpi at 1 bit
- Color and grayscale images should be scanned at 300 dpi at 8 bit
- Save each figure as its own file and do not include any extra text (ie, figure captions).
- Sizing: Save the image to the size of the final printed version with an allowance of not more than 10% larger.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors prior to submission.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
made a substantial contribution to the concept and design, acquisition of data or analysis and interpretation of data, drafted the article or revised it critically for important intellectual content, approved the version to be published.
Please ensure that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.
Please refer to the ICMJE Authorship guidelines at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
All contributors who do not meet the criteria for authorship should be listed in an ‘Acknowledgements’ section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity that paid for this assistance.
As part of the submission process you will be asked to provide the names of peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:
- The reviewer should have no prior knowledge of your submission
- The reviewer should not have recently collaborated with any of the authors
- Reviewer nominees from the same institution as any of the authors are not permitted
Please note that the Editors are not obliged to invite any recommended/opposed reviewers to assess your manuscript.
To comply with the guidance for Research Funders, Authors and Publishers issued by the Research Information Network (RIN), FAS additionally requires all Authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit Funding Acknowledgements on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding or state in your acknowledgments that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Declaration of Conflicting Interests
It is the policy of FAS to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please include any declaration at the end of your manuscript after any acknowledgements and prior to the references, under a heading ‘Conflict of interests’. If no declaration is made the following will be printed under this heading in your article: ‘None declared’. Alternatively, you may wish to state that ‘The Author(s) declare(s) that there is no conflict of interest’.
When making a declaration the disclosure information must be specific and include any financial relationship that all authors of the article has with any sponsoring organization and the for-profit interests the organization represents, and with any for-profit product discussed or implied in the text of the article.
Any commercial or financial involvements that might represent an appearance of a conflict of interest need to be additionally disclosed in the covering letter accompanying your article to assist the Editor in evaluating whether sufficient disclosure has been made within the Declaration of Conflicting Interests provided in the article.
For more information please visit the SAGE Journal Author Gateway.
All papers reporting animal and human studies must include whether written consent was obtained from the local Ethics Committee or Institutional Review Board. Please ensure that you have provided the full name and institution of the review committee and an Ethics Committee reference number.
We accept manuscripts that report human and/or animal studies for publication only if it is made clear that investigations were carried out to a high ethical standard. Studies in humans which might be interpreted as experimental (e.g. controlled trials) should conform to the Declaration of Helsinki http://www.wma.net/en/30publications/10policies/b3/index.html and typescripts must include a statement that the research protocol was approved by the appropriate ethical committee. In line with the Declaration of Helsinki 1975, revised Hong Kong 1989, we encourage authors to register their clinical trials (at http://clinicaltrials.gov or other suitable databases identified by the ICMJE, http://www.icmje.org/publishing_10register.html). If your trial has been registered, please state this on the Title Page. When reporting experiments on animals, indicate on the Title Page which guideline/law on the care and use of laboratory animals was followed.
Authors are required to ensure the following guidelines are followed, as recommended by the International Committee of Medical Journal Editors, Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.
Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. When informed consent has been obtained it should be indicated in the submitted article.
Contributor's Publishing Agreement
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive license agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and license to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
FAS and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of articles published in the journal. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked using duplication-checking software. Where an article is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article (removing it from the journal); taking up the matter with the head of department or dean of the author’s institution and/or relevant academic bodies or societies; banning the author from publication in the journal or all SAGE journals, or appropriate legal action.
Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
If you or your funder wishes your article to be freely available online to nonsubscribers immediately upon publication (gold open access), you can opt for it to be included in SAGE Choice, subject to the payment of a publication fee. The manuscript submission and peer review procedure is unchanged. On acceptance of your article, you will be asked to let SAGE know directly if you are choosing SAGE Choice. To check journal eligibility and the publication fee, please visit SAGE Choice. For more information on open access options and compliance at SAGE, including self/author archiving deposits (green open access) visit SAGE Publishing Policies on our Journal Author Gateway.
As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE has become a supporting member of ORCID, the Open Researcher and Contributor ID
ORCID provides a persistent digital identifier that distinguishes researchers from every other researcher and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities ensuring that their work is recognized.
The collection of ORCID iDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID iD you will be asked to associate that to your submission during the online submission process. If you do not already have an ORCID iD please follow this link to create one.